The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Fast Track, 2002Transgenic Model for Intraneuronal Oxidative Stress
One of the major questions we have often encountered in the Parkinson's disease (PD) study is why dopamine neurons in the substantia nigra of patient brains are selectively undergone degeneration....
-
Fast Track, 2002High Throughput Drug Screening for Protection Against DA Neuron Degeneration
We are utilizing a small worm called, C. elegans to develop a method to examine a large number of drugs that may protect against the type of cell death that occurs in Parkinson's disease (PD). The...
-
Fast Track, 2002Testosterone Therapy in Parkinson's disease
The University of Florida Movement Disorders Center will be following up the promising results of two preliminary studies of testosterone replacement therapy in male Parkinson's disease patients in a...
-
Fast Track, 2002Signaling Cascades Underlying Use-dependent Neuroprotection in Parkinsonism
Parkinson's disease is characterized by the progressive loss of nerves in the brain that produce a chemical called dopamine, which is important in the control of motor function. Current therapies...
-
Fast Track, 2002Differentiation catalysts for the production of dopaminergic neurons
Embryonic stem (ES) cells can replicate indefinitely in an undifferentiated state and develop into all cells and tissues in the body. These unique characters of ES cells imply their application as a...
-
Fast Track, 2002Pre-clinical Model for Pharmacological Upregulation of Molecular Chaperones
Lewy bodies including alpha-synuclein in substantia nigra neurons are characteristic of Parkinson's disease. These aggregates may cause the disease or may represent disease-causing protein folding...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.